By 1 2 1 News Reporter
Chandigarh,13th September:--- Post Graduate Institute of Medical Research (PGIMER), Johns Hopkins Bloomberg School of Public Health (JHSPH) and Global Health Strategies (GHS), have partnered to organize a symposium on, 'Rotavirus and Pentavalent Vaccines Innovations', on 14 September 2013 at the PGI campus in Chandigarh.
The Government of India has made strides towards addressing pneumonia and diarrhea which together account for 33 percent of under-five mortality in the country. Since 2011, it has successfully introduced the pentavalent vaccine in a phased manner across 9 states including Haryana which became the first state in North India to introduce the pentavalent vaccine in its immunization program. In addition, investments in research and development through successful public private partnerships have led to the development of India's first indigenous rotavirus vaccine. This symposium aims to bring together the scientific community, public health experts, government officials and development partners together to discuss the importance of preventive technologies, the learnings from the introduction of pentavalent vaccines as well as the road ahead for rotavirus vaccines. The symposium will be addressed by country's leading scientists and innovators including Dr. NK Ganguly, Distinguished Biotechnology Research Professor, Department of Biotechnology; Dr. Rajesh Kumar, Head of School of Public Health, PGIMER; Dr. Ajay Khera, Deputy Commissioner (Child Health and Immunization), Ministry of Health and Family Welfare; Dr. Rakesh Gupta, IAS, Mission Director, National Rural Health Mission, Haryana along with representatives from UNICEF, WHO and PGIMER. This event is expected to be attended by almost 80 participants including state and district officials and faculty members from various medical colleges and institutes across India as well as state representatives from Gujarat, Punjab, Tamil Nadu, Bihar,Delhi and Haryana.
No comments:
Post a Comment